-
-
-
-
-
-
-
AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability
-
-
-
-
-
-
-
AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on AngioDynamics (ANGO)
-
-
-
-
-
-
-
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System
-
-
-
-
-
-
-
AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance
-
-
-
-
-
-
-
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
-
-
-
-
-
-
-
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
-
1,207,994 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

